Enalaprilat: Solution for injection (1.25mg)

Detailed Information

ON THIS PAGE:
What is this Medicine?
In-Depth Information
Learn More
Patient Experiences

Also see:

Get answers to Frequently Asked Questions (FAQs)
Find other class related drugs
Find additional patient usage statistics

Visit Drug Summary Page

Check Drug Interactions

What is this Medicine?

ENALAPRILAT (e NAL a pril at) is an ACE inhibitor. This medicine is used to treat high blood pressure.

Similar Brand Name Drugs : Vasotec: Solution for injection (1.25mg)

In-Depth Information

Select a Medication

Enalaprilat 1.25mg/ml Solution for Injection (NOVAPLUS)

NDC: 004092122

Prescription Required
Not a Controlled Drug
(CSA Schedule)
FDA Approved

FDA approved for the following conditions:
Hypertension

Sometimes used for but not FDA approved for the following conditions:
Hypertensive Emergency, Hypertensive Urgency

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)

Enalaprilat 1.25mg/ml Solution for Injection (NOVAPLUS)

Ingredients

Close All Sections

Reported Side Effects for Enalaprilat 1.25mg/ml Solution for Injection (NOVAPLUS)

Skin Rash Incidence: 0.5-1.4%* Severity: MILD
Onset: EARLY

Constipation Incidence: 0.5-1.0%* Severity: MODERATE
Onset: DELAYED

Heart Attack Incidence: 0.5-1.2%* Severity: SEVERE
Onset: DELAYED

Lightheadedness Incidence: 0.5-7.9%* Severity: MILD
Onset: EARLY

Fainting Incidence: 0.5-2.2%* Severity: MILD
Onset: EARLY

Fever Incidence: 0.5-1.0%* Severity: MILD
Onset: EARLY

Tired Incidence: 0.5-3.0%* Severity: MILD
Onset: EARLY

Low Blood Pressure Incidence: 0.9-6.7%* Severity: MODERATE
Onset: RAPID

High Potassium Level Incidence: 1.0-3.8%* Severity: SEVERE
Onset: DELAYED

Upset Stomach Incidence: 1.1-1.4%* Severity: MILD
Onset: EARLY

Weakness Incidence: 1.1-1.6%* Severity: MILD
Onset: DELAYED

Vomiting Incidence: 1.3%* Severity: MILD
Onset: EARLY

Cough Incidence: 1.3-2.2%* Severity: MILD
Onset: DELAYED

Shortness Of Breath Incidence: 1.3%* Severity: MODERATE
Onset: EARLY

Loose Stools Incidence: 1.4-2.1%* Severity: MILD
Onset: EARLY

Chest Pain Incidence: 1.5%* Severity: MODERATE
Onset: EARLY

Balance Problems Incidence: 1.6%* Severity: MILD
Onset: EARLY

Postural Low Blood Pressure Incidence: 1.6%* Severity: MODERATE
Onset: DELAYED

Stomach Pain Incidence: 1.6%* Severity: MILD
Onset: EARLY

Headache Incidence: 1.8-5.2%* Severity: MILD
Onset: EARLY

Chest Pain Incidence: 2.1%* Severity: MODERATE
Onset: EARLY

*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.

Daily Life Interactions for Enalaprilat 1.25mg/ml Solution for Injection (NOVAPLUS)

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Close All Interactions

Moderate Lifestyle Interaction

Alcohol and Enalaprilat 1.25mg/ml Solution for Injection (NOVAPLUS)(Enalaprilat)

Alcohol and Antihypertensives(Enalaprilat)

Although an interaction is possible, Ethanol (alchohol) and Antihypertensive Agents (drugs used to reduce high blood pressure) may be used together. Ethanol or alchohol-containing beverages may increase the effects of Antihypertensive Agents on your blood pressure. If the blood pressure drops too low while taking Ethanol and Antihypertensive Agents, you may become dizzy or feel faint. To limit this interaction, avoid alcohol-containing beverages while taking medicines to lower your blood pressure. Do not stand or sit up too quickly. Contact your prescriber if you have dizziness which does not go away.

Check Drug Interactions

Pregnancy & Lactation Information

FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester